UN&UP receives prestigious NIH CRP award for its Novel TheraLode™ Thrombolysis Platform

We are thrilled to share that UN&UP has received an NIH CRP award to assess the preclinical efficacy of its innovative TheraLode™ Thrombolysis Platform in partnership with the prestigious Henry Ford Neuroscience Institute, and additional support from Washington University in St. Louis.

We extend our gratitude to our clinical research partners, who, as key opinion leaders in the field, continue to champion our mission to transform stroke care by improving the safety and efficacy of thrombolysis, enabling treatment for ten times more stroke victims.

Our esteemed collaborators include Dr. Colin Derdeyn (University of Virginia), Dr. Thomas Hemmen (UCSD), Dr. Peter Panagos (Washington University), Dr. Bruce Campbell (Royal Melbourne University), Dr. Jin-Moo Lee (Washington University), and Drs. Michael Chopp and Li Zhang (Henry Ford Health System). We also thank the St. Louis BioGenerator for its immense support in advancing this effort.